{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:16:34Z","timestamp":1783444594364,"version":"3.54.6"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Guillain-Barr\u00e9 syndrome (GBS) is associated with various types of preceding infections including <jats:italic>Campylobacter jejuni<\/jats:italic> and cytomegalovirus, but there is also an association with arthropod borne viruses (arboviruses), such as Zika virus, that are endemic in tropical regions. Here we present the clinical characteristics of 12 GBS patients from Suriname that were hospitalized between the beginning of 2016 and half 2018. Extensive diagnostic testing was performed for pathogens that are commonly associated with GBS, but also for arboviruses, in order to identify the preceding infection that might have led to GBS. With this extensive testing algorithm, we could identify a recent infection in six patients of which four of them had evidence of a recent Zika virus or dengue virus infection. These results suggest that arboviruses, specifically Zika virus but possibly also dengue virus, might be important causative agents of GBS in Suriname. Furthermore, we found that more accessibility of intravenous immunoglobulins or plasma exchange could improve the treatment of GBS in Suriname.<\/jats:p>","DOI":"10.3389\/fneur.2021.635753","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T17:09:05Z","timestamp":1612976945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Guillain-Barr\u00e9 Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections"],"prefix":"10.3389","volume":"12","author":[{"given":"Thomas","family":"Langerak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"van Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Doornekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion P. G.","family":"Koopmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine H.","family":"GeurtsvanKessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Rockx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Adriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C. M.","family":"van Gorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain."},{"key":"B3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barre syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/acn3.556","article-title":"Zika virus and Guillain-Barre syndrome in Bangladesh","volume":"5","author":"GeurtsvanKessel","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barre syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/jiz063","article-title":"Zika virus seroprevalence in urban and rural areas of Suriname, 2017","volume":"220","author":"Langerak","year":"2019","journal-title":"J Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/vox.12370","article-title":"Estimating the risk of dengue transmission from Dutch blood donors travelling to Suriname and the Dutch Caribbean","volume":"110","author":"Oei","year":"2016","journal-title":"Vox Sang."},{"key":"B11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.pediatrneurol.2007.05.020","article-title":"Concomitant transverse myelitis and acute motor axonal neuropathy in an adolescent","volume":"37","author":"Howell","year":"2007","journal-title":"Pediatr Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pediatrneurol.2010.08.013","article-title":"Risk factors and outcomes of Guillain-Barre syndrome with acute myelitis","volume":"44","author":"Lin","year":"2011","journal-title":"Pediatr Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jns.2018.09.028","article-title":"Concurrent Guillain-Barre syndrome, transverse myelitis and encephalitis post-Zika: a case report and review of the pathogenic role of multiple arboviral immunity","volume":"395","author":"Mancera-Paez","year":"2018","journal-title":"J Neurol Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fneur.2016.00233","article-title":"Zika virus infection and guillain-barre syndrome in three patients from Suriname","volume":"7","author":"Langerak","year":"2016","journal-title":"Front Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/infdis\/jiy164","article-title":"Longitudinal analysis of antibody cross-neutralization following zika virus and dengue virus infection in Asia and the Americas","volume":"218","author":"Montoya","year":"2018","journal-title":"J Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1128\/CVI.00487-14","article-title":"Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy","volume":"21","author":"Prince","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1073\/pnas.84.2.570","article-title":"Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection","volume":"84","author":"Henle","year":"1987","journal-title":"Proc Natl Acad Sci USA."},{"key":"B19","unstructured":""},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/currents.outbreaks.ff0f6190d5431c2a2e824255eaeaf339","article-title":"Zika virus outbreak in Suriname, a report based on laboratory surveillance data","author":"Codrington","year":"2018","journal-title":"PLOS Currents Outbreaks"},{"key":"B21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3201\/eid2305.161630","article-title":"Lack of durable cross-neutralizing antibodies against zika virus from dengue virus infection","volume":"23","author":"Collins","year":"2017","journal-title":"Emerg Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1473-3099(03)00543-7","article-title":"Epstein-Barr virus-recent advances","volume":"3","author":"Macsween","year":"2003","journal-title":"Lancet Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13256-018-1626-y","article-title":"Dengue fever complicated with Guillain-Barre syndrome: a case report and review of the literature","volume":"12","author":"Dalugama","year":"2018","journal-title":"J Med Case Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4103\/0972-2327.91946","article-title":"Neurological complications of dengue fever: experience from a tertiary center of north India","volume":"14","author":"Verma","year":"2011","journal-title":"Ann Indian Acad Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1590\/S0004-282X2004000100025","article-title":"Guillain-Barre syndrome in the course of dengue: case report","volume":"62","author":"Santos","year":"2004","journal-title":"Arq Neuropsiquiatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/BF01962343","article-title":"Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay","volume":"7","author":"Herbrink","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.635753\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T17:09:07Z","timestamp":1612976947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.635753\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":26,"alternative-id":["10.3389\/fneur.2021.635753"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.635753","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"article-number":"635753"}}